000			01809nam a2200349 a 4500
001			ebr10671002
003			CaPaEBR
006			m u
007			cr cn|||||||||
008			090630s2009 nyu sb 001 0 eng d
010			_z 2009027054
020			_z9781606928431 (hardcover)
020			_z9781613243725 (e-book)
040			_aCaPaEBR _cCaPaEBR
035			_a(OCoLC)705945748
043			_an-us---
050	1	4	_aRS55.2 _b.G465 2009eb
082	0	4	_a338.4/76151 _222
245	0	0	_aGeneric drugs _h[electronic resource] : _bneeds and issues / _cRyan S. Blanton, editor.
260			_aNew York : _bNova Science Publishers, _c2009.
300			_a157 p.
490	1		_aHealth care issues, costs and access
504			_aIncludes bibliographical references and index.
505	0		_aAuthorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, January 17, 2007 / U.S. Government Printing Office -- Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on Oversight and Government Reform, House of Representatives, March 26, 2007 / U.S. Government Printing Office.
533			_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2013. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries.
650		0	_aGeneric drugs _zUnited States.
655		7	_aElectronic books. _2local
700	1		_aBlanton, Ryan S.
710	2		_aebrary, Inc.
830		0	_aHealth care issues, costs, and access.
856	4	0	_uhttp://site.ebrary.com/lib/rucke/Doc?id=10671002 _zAn electronic book accessible through the World Wide Web; click to view
999			_c162007 _d162007